CLINICAL_TRIALS
trial_result
· 2021-08-26
Clinical Trial Update: Escalated Therapy of Scabies With INFECTOSCAB 5% (Permethrin) [Phase 3]
Summary
Phase 3 clinical trial update for INFECTOSCAB 5% (Permethrin) in treating scabies.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Infectopharm Arzneimittel GmbH | Conditions: Scabies | Phase 3 | Status: UNKNOWN